The problem of compliance to cholesterol altering therapy

Journal of Internal Medicine

Volumn 241, Issue 4, 1997, Pages 317-325

  Insull, W ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUINDOSTATIN;

CLINICAL PRACTICE; CONFERENCE PAPER; CORONARY ARTERY DISEASE; COST BENEFIT ANALYSIS; DRUG MONITORING; HEALTH CARE PERSONNEL; HYPERCHOLESTEROLEMIA; MEASUREMENT; PATIENT CARE; PATIENT COMPLIANCE; PRIORITY JOURNAL; STAFF TRAINING; UNITED STATES;

EID: 0031006115     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1997.112133000.x     Document Type: Conference Paper

References (24)

1. Haynes RB, Taylor DW, Sackett DL. eds. Compliance in Health Care. Baltimore: Johns Hopkins 1979; 516.
2. Shumaker SA, Schron EB, Okene JK, eds. The Handbook of Health Behavior Change, New York: Springer 1990; 474.
3. Cramer JA, Spilker B, eds. Patient Compliance in Medical Practice and Clinical Trials. New York: Raven 1991.
4. Rudd P. Compliance with antihypertensive therapy, a shifting paradigm. Cardiol Rev 1994; 2:5, 230-40.
5. Lipid Research Clinic Program. The Lipid Research Clinics Coronary Primary Prevention Trial Results. I Reduction in Incidence of Coronary Heart Disease. JAMA 1984; 251: 351-64.
6. Coronary Drug Project Research Group. Clofibrate and Niacin in Coronary Heart Disease. JAMA 1975; 231: 360-81.
7. Prick MH, Elo O, Haapa K. et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle aged men with dyslipidemia. N Engl J Med 1987; 317: 1237-45.
8. Bradford RH, Shear CL, Chremos AN, et al. Expanded Clinical Evaluation of Lovastatin (EXCELL) study result, I Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemia. Arch Int Med 1991; 151: 43-9.
9. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S), Lancet 1994; 344: 1383-9.
10. White HD, Patel H, Strategies to improve patient compliance. In: Woodford FP, Davignon J, Sniderman A. eds. Atherosclerosis X. 1995 Excerpta Med. Elsevier, New York 147-58.
11. Shepherd J, Cobbe SM, Ford I et al. Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia. N Engl J Med 1995; 333: 1301-7.
12. CARE Study Group. Coronary and Recurrent Events. Presented to the Am Col Cardiol Orlando March 26, 1996.
13. Andrade S et al. Discontinuation of antihyperlipidemic drugs - Do rates reported in clinical trials reflect rates in primary care settings? N Engl J Med 1995; 332: 1125-31.
14. Cramer JA, Mattson RH. Monitoring compliance with antiepileptic drug therapy. In: Cramer JA, Spilker B. eds. Patient Compliance in Medical Practice and Clinical Trials. Raven New York 1991; 123.
15. Insull W, Silvers A, Troendle A, Dunne CW. Substantial non-compliance to dose and time prescriptions for medications treating hypercholesterolemia. Atheroscler 1995; 115 (Suppl,) S93.
16. Kruse WH-H. Compliance with treatment of hyperlipoproteinemia in medical practice and clinical trials. In: Cramer JA, Spilker B, eds. Patient Compliance in Medical Practice and Clinical Trials. New York: Raven Press 1991; 175-86.
17. Lipid Research Clinic Program. The Lipid Research Clinics Coronary Primary Prevention Trial Results. II Relationship of Reduction in Incidence of Coronary Heart Disease to Cholesterol Lowering. JAMA 1984; 251: 365-74.
18. Russell ML. Behavioral Counseling in Medicine. Strategies for Modifying At-Risk Behavior. Oxford. New York 1986; 327.
19. Hunninghake DB. Approach to improve patient compliance. In: Woodford FP, Davignon J, Sniderman A, eds. Atherosclerosis X. Excerpta Med. Elsevier. New York, 1995: 154-8.
20. Taylor CB, Miller NH. The behavioral approach. In: Wenger NK, Weinstein HK. eds. Rehabilitation of the coronary patient. New York: Churchill Livingstone 1992: 461-71.
21. Russell ML, Insull W, Probsrfield JL. Examination of medical professions for counseling on medication adherence. Am J Med 1985; 78: 277-82.
22. Probstifield JL, Russell ML, Insull W, Yusuf S. Dropouts from a clinical trial, their recovery and characterization: a basis for dropout management and prevention. In: Shumaker SA. Schron EB, Okene JK, eds. The Handbook of Health Behavior Change. New York: Springer 1990; 376-400.
23. Guerrero D, Rudd P. Bryant-Kosling C. Middleton BF. Antihypertensive medication-taking, investigation of a simple regimen. Am J Hypertens 1993; 6: 586-92.
24. Davis DE, Fox RD, eds. The Physician as Learner: Linking Research to Practice. American Medical Association, Chicago, 1994; 366.